Plus Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
HRT FINANCIAL LP | 05/15/2025 | 102.07 K | $96.00 K | 100.00% | 1.73% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 80.51 K | $76.49 K | 100.00% | 1.37% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 57.05 K | $54.21 K | -1.89% | 0.97% |
VIRTU FINANCIAL LLC | 05/12/2025 | 40.03 K | $38.00 K | 100.00% | 0.68% |
UBS GROUP AG | 05/13/2025 | 33.44 K | $31.77 K | 100.00% | 0.57% |
VANGUARD GROUP INC | 05/09/2025 | 32.54 K | $30.91 K | 0.00% | 0.55% |
TWO SIGMA SECURITIES, LLC | 05/15/2025 | 13.61 K | $12.93 K | -6.70% | 0.23% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 7.68 K | $7.29 K | 60.52% | 0.13% |
BLACKROCK, INC. | 05/02/2025 | 6.96 K | $6.61 K | 0.00% | 0.12% |
GROUND SWELL CAPITAL, LLC | 05/13/2025 | 13.66 K | $12.98 K | 100.00% | 0.02% |
BARCLAYS PLC | 05/15/2025 | 1.04 K | $1.00 K | 100.00% | 0.02% |
05/02/2025 | 258 | $245 | 290.91% | 0.00% | |
CITIGROUP INC | 05/12/2025 | 146 | $139 | 100.00% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 133 | $126 | 0.00% | 0.00% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 50 | $48 | 4.17% | 0.00% |
GROUP ONE TRADING, L.P. | 05/14/2025 | 1 | $1 | 0.00% | 0.00% |
AIGH CAPITAL MANAGEMENT LLC | 05/06/2025 | 0 | $0 | -100.00% | 0.00% |
Plus Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 19 institutional investors and hedge funds held shares of Plus Therapeutics, Inc.. The most heavily invested institutionals were:
HRT FINANCIAL LP: 102,065
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 80,505
GEODE CAPITAL MANAGEMENT, LLC: 57,053
Virtu Financial LLC: 40,030
UBS Group AG: 33,437
VANGUARD GROUP INC: 32,541
6.60% of Plus Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 395.87 K shares in the last 24 months. This purchase volume represents approximately $117.34 K in transactions.